Identification of distinct blood-based biomarkers in early stage of Parkinson’s disease
出版年份 2019 全文链接
标题
Identification of distinct blood-based biomarkers in early stage of Parkinson’s disease
作者
关键词
-
出版物
NEUROLOGICAL SCIENCES
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-12-11
DOI
10.1007/s10072-019-04165-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Plasma alpha-synuclein levels in patients with Parkinson’s disease: a systematic review and meta-analysis
- (2019) Anastasia Bougea et al. NEUROLOGICAL SCIENCES
- The clinical symptoms of Parkinson's disease
- (2016) Sigurlaug Sveinbjornsdottir JOURNAL OF NEUROCHEMISTRY
- Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight
- (2015) Aashiq Hussain Bhat et al. BIOMEDICINE & PHARMACOTHERAPY
- Potential utility of autoantibodies as blood-based biomarkers for early detection and diagnosis of Parkinson’s disease
- (2015) Cassandra A. DeMarshall et al. IMMUNOLOGY LETTERS
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- Biomarkers of Parkinson’s disease: Present and future
- (2015) Diane B. Miller et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Assessment of Protective Role of Multifunctional Dopamine Agonist D-512 Against Oxidative Stress Produced by Depletion of Glutathione in PC12 Cells: Implication in Neuroprotective Therapy for Parkinson’s Disease
- (2015) Chandrashekhar Voshavar et al. NEUROTOXICITY RESEARCH
- Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease
- (2015) Brent J. Ryan et al. TRENDS IN BIOCHEMICAL SCIENCES
- Deregulation of protein translation control, a potential game-changing hypothesis for Parkinson's disease pathogenesis
- (2015) Jean-Marc Taymans et al. TRENDS IN MOLECULAR MEDICINE
- Estimating the direct and indirect costs associated with Parkinson’s disease
- (2015) Carmen Rodríguez-Blázquez et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation
- (2015) Sonia George et al. Journal of Parkinsons Disease
- Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson’s Disease Patients
- (2015) Jose A. Santiago et al. PLoS One
- Low clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study
- (2014) C. H. Adler et al. NEUROLOGY
- Gene Ontology Consortium: going forward
- (2014) NUCLEIC ACIDS RESEARCH
- Inhibition of the Fe(III)-Catalyzed Dopamine Oxidation by ATP and Its Relevance to Oxidative Stress in Parkinson’s Disease
- (2013) Dianlu Jiang et al. ACS Chemical Neuroscience
- Therapeutic prospects for Parkinson disease
- (2013) C. Warren Olanow et al. ANNALS OF NEUROLOGY
- Deep brain stimulation modulates nonsense-mediated RNA decay in Parkinson’s patients leukocytes
- (2013) Lilach Soreq et al. BMC GENOMICS
- The Role of Inflammatory and Oxidative Stress Mechanisms in the Pathogenesis of Parkinson’s Disease: Focus on Astrocytes
- (2013) Rituraj Niranjan MOLECULAR NEUROBIOLOGY
- Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease
- (2013) Amaal AlDakheel et al. Neurotherapeutics
- Signaling Pathways Involved in 1-Octen-3-ol-Mediated Neurotoxicity in Drosophila melanogaster: Implication in Parkinson’s Disease
- (2013) Arati A. Inamdar et al. NEUROTOXICITY RESEARCH
- Statistical analysis and mapping of the unified Parkinson’s Disease rating scale to Hoehn and Yahr staging
- (2012) Athanasios Tsanas et al. PARKINSONISM & RELATED DISORDERS
- DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease
- (2012) Xiangmin Lin et al. Scientific Reports
- Mitochondria and Programmed Cell Death in Parkinson's Disease: Apoptosis and Beyond
- (2011) Celine Perier et al. ANTIOXIDANTS & REDOX SIGNALING
- Parkinsonism: Onset, progression, and mortality
- (2011) M. Hoehn et al. NEUROLOGY
- ATP-Binding Cassette Transporters and Their Roles in Protecting the Brain
- (2011) Ayman ElAli et al. NEUROSCIENTIST
- Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times
- (2010) Ying Jiao Zhao et al. MOVEMENT DISORDERS
- Clinical Criteria for the Diagnosis of Parkinson’s Disease
- (2010) Heinz Reichmann Neurodegenerative Diseases
- Selegiline use is associated with a slower progression in early Parkinson’s disease as evaluated by Hoehn and Yahr Stage transition times
- (2010) Y.J. Zhao et al. PARKINSONISM & RELATED DISORDERS
- Comparative responsiveness of Parkinson's disease scales to change over time
- (2009) Anette Schrag et al. MOVEMENT DISORDERS
- KEGG for representation and analysis of molecular networks involving diseases and drugs
- (2009) Minoru Kanehisa et al. NUCLEIC ACIDS RESEARCH
- Limbic and Frontal Cortical Degeneration Is Associated with Psychiatric Symptoms in PINK1 Mutation Carriers
- (2008) Kathrin Reetz et al. BIOLOGICAL PSYCHIATRY
- Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1)
- (2008) Ryan D. Mills et al. JOURNAL OF NEUROCHEMISTRY
- The history of dopamine and levodopa in the treatment of Parkinson's disease
- (2008) Stanley Fahn MOVEMENT DISORDERS
- LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson's disease
- (2007) J. Alegre-Abarrategui et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- A formula for the conversion of UPDRS-III scores to Hoehn and Yahr stage
- (2007) Blake K. Scanlon et al. PARKINSONISM & RELATED DISORDERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search